Market Insights Health OTC Pharmaceuticals

Analgesics - Kazakhstan

Kazakhstan

In Kazakhstan, the revenue in the Analgesics market reached US$127.10m in 2024.
It is projected that the market will experience an annual growth rate of 6.73% (CAGR 2024-2029).
When compared on a global scale, the in the United States generates the highest revenue in this market, with US$7,243.00m in 2024.
In terms of per capita figures, each person in Kazakhstan generates revenues of US$6.41 in 2024.
Despite a growing demand for analgesics in Kazakhstan, the market is dominated by foreign multinational pharmaceutical companies.

Key regions: Canada, United States, United Kingdom, Australia, Germany

Market

Region

Region comparison

Currency

Analyst Opinion

The Analgesics market in Kazakhstan has been experiencing significant growth in recent years.

Customer preferences: Kazakhstan is a country with a high prevalence of chronic pain conditions, such as arthritis and back pain. As a result, there is a strong demand for analgesic products in the country. Customers in Kazakhstan prefer over-the-counter analgesics, as they are easily accessible and provide quick relief from pain. The convenience of purchasing these products without a prescription is particularly appealing to customers who may not have easy access to healthcare services. Additionally, customers in Kazakhstan have shown a preference for analgesics that have minimal side effects and are affordable.

Trends in the market: One of the key trends in the Analgesics market in Kazakhstan is the increasing popularity of natural and herbal remedies. Customers are becoming more conscious of the potential side effects of traditional analgesics and are seeking alternative options. This has led to a rise in the demand for products that are made from natural ingredients and have a more holistic approach to pain relief. Manufacturers are responding to this trend by introducing a wide range of natural analgesic products in the market.Another trend in the market is the growing popularity of online sales channels. Customers in Kazakhstan are increasingly turning to online platforms to purchase analgesics due to the convenience and ease of use. Online sales channels provide customers with a wide range of options and the ability to compare prices and read reviews before making a purchase. This trend has led to increased competition among manufacturers and retailers, as they strive to capture a larger share of the online market.

Local special circumstances: Kazakhstan has a rapidly aging population, which is contributing to the growth of the Analgesics market. As people age, they are more likely to experience chronic pain conditions and require analgesic products for relief. This demographic shift is driving the demand for analgesics in the country.Additionally, the healthcare infrastructure in Kazakhstan is still developing, especially in rural areas. This has led to a reliance on over-the-counter analgesics for pain management, as access to healthcare services may be limited. The availability of over-the-counter analgesics in local pharmacies and supermarkets has made them a convenient and accessible option for customers.

Underlying macroeconomic factors: The growing middle class in Kazakhstan is a key driver of the Analgesics market. As disposable incomes increase, customers have more purchasing power to spend on healthcare products, including analgesics. This has led to a higher demand for premium analgesic products that offer additional benefits, such as extended release or targeted pain relief.Furthermore, the government of Kazakhstan has implemented healthcare reforms aimed at improving access to healthcare services. These reforms include the expansion of health insurance coverage and the development of primary healthcare centers. As a result, more people are seeking medical treatment and are being prescribed analgesics by healthcare professionals, which is contributing to the growth of the market.In conclusion, the Analgesics market in Kazakhstan is experiencing growth due to customer preferences for over-the-counter analgesics, the increasing popularity of natural remedies, the rise of online sales channels, the country's aging population, the limited healthcare infrastructure in rural areas, the growing middle class, and government healthcare reforms.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.